Name: NOVARTIS AG-SPONSORED ADR (NVS) Stock
Brand: NOVARTIS AG-SPONSORED ADR
Rating: 8 (3 reviews)

NVS Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials

19 days ago - By: Chartmill

NOVARTIS AG-SPONSORED ADR (NYSE:NVS): A Comprehensive Value Investment Analysis

4 days ago - By: Benzinga

Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder

5 days ago - By: Bloomberg

Novartis Strikes $1.7 Billion Drug Target Deal With UK Biotech

6 days ago - By: The Motley Fool - Mentions: VYMI HSBC

Can the Vanguard International High Dividend Yield Index Fund ETF Shares Outperform Again in 2026?

6 days ago - By: The Motley Fool - Mentions: ALNY SNY REGN BIIB ...

Is Alnylam Pharmaceuticals a Millionaire Maker?

8 days ago - By: Zacks Investment Research - Mentions: BMY GILD

Will Breyanzi's Label Expansion Boost BMY's CAR T Cell Therapy Sales?

10 days ago - By: Zacks Investment Research

Here's Why Novartis (NVS) is a Strong Value Stock

10 days ago - By: CNBC - Mentions: NVDA ORCL AAPL AVGO ...

Here are Wednesday's biggest analyst calls: Nvidia, Oracle, Apple, Broadcom, ASML, Marvell, Ralph Lauren & more

11 days ago - By: Stocktwits - Mentions: JANX BAC

Janux Therapeutics Stock Sinks 50% After Prostate Cancer Trial Triggers Target Cuts Across Wall Street — Retail Sees A FOMO-Fueled Rebound

16 days ago - By: Zacks Investment Research

Here's Why Novartis (NVS) is a Strong Momentum Stock

18 days ago - By: Zacks Investment Research - Mentions: FOLD RNA

FDA Greenlights Novartis' Gene Replacement Treatment for SMA

18 days ago - By: CNBC - Mentions: NVDA AAPL TSLA MSFT ...

Here are Tuesday's biggest analyst calls: Nvidia, Apple, Tesla, Microsoft, Oracle, Live Nation, Coinbase & more

18 days ago - By: Stocktwits

Novartis Stock Rises Premarket After FDA Approves First Gene Therapy For Teens And Adults With Muscle-Weakening Disorder

22 days ago - By: Zacks Investment Research - Mentions: FOLD RNA

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth

23 days ago - By: BioMedWire - Mentions: OTLC IOBT BCAX PFE

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

23 days ago - By: CNBC

Novartis targets 5%-6% annual sales growth until 2030 on key cancer drugs

23 days ago - By: Stocktwits

Novartis Stock Softens Premarket Even As It Raises 2030 Outlook, Sales Guidance For Two Key Cancer Drugs

23 days ago - By: Bloomberg

Novartis Raises Peak Sales Targets for Key Cancer Drugs

24 days ago - By: Stocktwits - Mentions: UNH MRK BMY

Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices

25 days ago - By: Benzinga

NOVARTIS AG-SPONSORED ADR (NVS) Stock News